-transparent.png){kind=logo}
New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives. 2000
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
Centre d'Etudes et de Recherche sur le Médicament de Normandie, Laboratoire de Pharmacochimie, UFR des Sciences Pharmaceutiques, Caen, France.
We report herein the design and the synthesis of some aryl-substituted pyrrolizine and indolizine derivatives, on the basis of a hypothetical pharmacophore structure designed to fit the catalytic site of the human cytochrome P450 aromatase. The in vitro biological evaluation of these compounds allowed us to point out two new potent non-steroidal aromatase inhibitors, MR 20494 and MR 20492, with IC50 values in the range of 0.1 microM.
Related Publications
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
September 1991,
Journal of medicinal chemistry,
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
November 1991,
Archiv der Pharmazie,
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
April 2002,
Bioorganic & medicinal chemistry letters,
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
June 1985,
Journal of medicinal chemistry,
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
February 1977,
Journal of pharmaceutical sciences,
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
December 1995,
Chemical & pharmaceutical bulletin,
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
October 2021,
Molecules (Basel, Switzerland),
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
January 2006,
Bioorganic & medicinal chemistry letters,
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
February 2002,
Bioorganic & medicinal chemistry,
P Sonnet, and
P Dallemagne, and
J Guillon, and
C Enguehard, and
S Stiebing, and
J Tanguy, and
R Bureau, and
S Rault, and
P Auvray, and
S Moslemi, and
P Sourdaine, and
G E Séralini
October 1991,
Archiv der Pharmazie,
